Modeling treatment of cancer using oncolytic virotherapy with saturated incidence
DOI10.1080/07362994.2019.1703743zbMATH Open1444.92045OpenAlexW2996801417WikidataQ126526730 ScholiaQ126526730MaRDI QIDQ5113868FDOQ5113868
Mini Ghosh, Maharajan Rajalakshmi
Publication date: 18 June 2020
Published in: Stochastic Analysis and Applications (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/07362994.2019.1703743
Recommendations
- Modeling treatment of cancer using virotherapy with generalized logistic growth of tumor cells
- Dynamics of tumor virotherapy: a deterministic and stochastic model approach
- Dynamical behavior of a new oncolytic virotherapy model based on gene variation
- Mathematical analysis for oncolytic virotherapy
- Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy
Medical applications (general) (92C50) Bifurcation theory for ordinary differential equations (34C23) Applications of stochastic analysis (to PDEs, etc.) (60H30)
Cites Work
- MATCONT
- Disease transmission models with density-dependent demographics
- Mathematical modeling of cancer radiovirotherapy
- An Îto stochastic differential equations model for the dynamics of the MCF-7 breast cancer cell line treated by radiotherapy
- Stochastic models for virus and immune system dynamics
- Memory versus effector immune responses in oncolytic virotherapies
- Dynamics of tumor virotherapy: A deterministic and stochastic model approach
- A mathematical model for cell cycle-specific cancer virotherapy
- Modeling treatment of cancer using virotherapy with generalized logistic growth of tumor cells
Cited In (5)
- Title not available (Why is that?)
- Basic stochastic model for tumor virotherapy
- Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I
- Mathematical model of optimal chemotherapy and oncolytic virotherapy
- Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
Uses Software
This page was built for publication: Modeling treatment of cancer using oncolytic virotherapy with saturated incidence
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5113868)
